| Reactive astrocyte nomenclature, definitions, and future directions C Escartin, E Galea, A Lakatos, JP O’Callaghan, GC Petzold, ... Nature neuroscience 24 (3), 312-325, 2021 | 1447 | 2021 |
| Histopathological findings in brain tissue obtained during epilepsy surgery I Blumcke, R Spreafico, G Haaker, R Coras, K Kobow, CG Bien, M Pfäfflin, ... New England Journal of Medicine 377 (17), 1648-1656, 2017 | 768 | 2017 |
| Mapping microglia states in the human brain through the integration of high-dimensional techniques R Sankowski, C Böttcher, T Masuda, L Geirsdottir, Sagar, E Sindram, ... Nature neuroscience 22 (12), 2098-2110, 2019 | 349 | 2019 |
| Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma D Henrik Heiland, VM Ravi, SP Behringer, JH Frenking, J Wurm, ... Nature communications 10 (1), 2541, 2019 | 293 | 2019 |
| Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma VM Ravi, P Will, J Kueckelhaus, N Sun, K Joseph, H Salié, L Vollmer, ... Cancer cell 40 (6), 639-655. e13, 2022 | 216 | 2022 |
| T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10 VM Ravi, N Neidert, P Will, K Joseph, JP Maier, J Kückelhaus, L Vollmer, ... Nature communications 13 (1), 925, 2022 | 147 | 2022 |
| Tryptophan metabolism drives dynamic immunosuppressive myeloid states in IDH-mutant gliomas M Friedrich, R Sankowski, L Bunse, M Kilian, E Green, ... Nature cancer 2 (7), 723-740, 2021 | 140 | 2021 |
| Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumours FL Ricklefs, CL Maire, R Reimer, L Dührsen, K Kolbe, M Holz, ... Journal of Extracellular Vesicles 8 (1), 1588555, 2019 | 109 | 2019 |
| Comprehensive analysis of PD-L1 expression in glioblastoma multiforme DH Heiland, G Haaker, D Delev, B Mercas, W Masalha, S Heynckes, ... Oncotarget 8 (26), 42214, 2017 | 99 | 2017 |
| Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification CL Maire, MM Fuh, K Kaulich, KD Fita, I Stevic, DH Heiland, JA Welsh, ... Neuro-oncology 23 (7), 1087-1099, 2021 | 74 | 2021 |
| Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience R Hoefflin, AL Geißler, R Fritsch, R Claus, J Wehrle, P Metzger, M Reiser, ... JCO Precision Oncology 2, 1-16, 2018 | 65 | 2018 |
| Hippocampusavoidance wholebrain radiation therapy with a simultaneous integrated boost for multiple brain metastases I Popp, S Rau, M Hintz, J Schneider, A Bilger, JT Fennell, DH Heiland, ... Cancer 126 (11), 2694-2703, 2020 | 52 | 2020 |
| Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects S Jain, JW Rick, RS Joshi, A Beniwal, J Spatz, S Gill, ACC Chang, ... The Journal of clinical investigation 133 (5), 2023 | 51 | 2023 |
| Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy W Masalha, DH Heiland, P Franco, D Delev, JG Haaker, O Schnell, ... Journal of Neuro-Oncology 136, 147-154, 2018 | 49 | 2018 |
| Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology VM Ravi, K Joseph, J Wurm, S Behringer, N Garrelfs, P d’Errico, Y Naseri, ... Life science alliance 2 (4), 2019 | 47 | 2019 |
| Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system D Delev, DH Heiland, P Franco, P Reinacher, I Mader, O Staszewski, ... Journal of neuro-oncology 141, 223-233, 2019 | 47 | 2019 |
| The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation H Saleem, UK Abdul, A Küçükosmanoglu, M Houweling, ... Drug Resistance Updates 43, 29-37, 2019 | 46 | 2019 |
| Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas JA Mutter, SK Alig, MS Esfahani, EM Lauer, J Mitschke, DM Kurtz, J Kühn, ... Journal of Clinical Oncology 41 (9), 1684-1694, 2023 | 44 | 2023 |
| Crosslink between Temozolomide and PD-L1 immune-checkpoint inhibition in glioblastoma multiforme S Heynckes, K Daka, P Franco, A Gaebelein, JH Frenking, ... BMC cancer 19, 1-7, 2019 | 44 | 2019 |
| Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine DH Heiland, W Masalha, P Franco, MR Machein, A Weyerbrock Journal of neuro-oncology 126, 567-575, 2016 | 41 | 2016 |
